Cibus, Inc. (CBUS) stock
CBUSNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30166% above fair value
$1.39+0.19 (+15.83%)
Close on Nov 17, 2026Market cap $106.24MP/E –Yield –
Cibus EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cibus's EPS for the twelve months ending Jun 30, 2026 was -$1.65. For fiscal 2025 it was -$2.78. The highest annual figure on record is -$2.78 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.78 | – |
| FY2024 | Dec 31, 2024 | -$10.83 | – |
| FY2023 | Dec 31, 2023 | -$25.95 | – |
| FY2022 | Dec 31, 2022 | -$18.36 | – |
| FY2021 | Dec 31, 2021 | -$39.00 | – |
| FY2020 | Dec 31, 2020 | -$66.00 | – |
| FY2019 | Dec 31, 2019 | -$60.50 | – |
| FY2018 | Dec 31, 2018 | -$45.50 | – |
| FY2017 | Dec 31, 2017 | -$56.00 | – |
| FY2016 | Dec 31, 2016 | -$31.00 | – |
| FY2015 | Dec 31, 2015 | -$44.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.29 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.33 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.59 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.44 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.61 | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.34 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.87 | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.63 | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.14 | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.12 | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.53 | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.59 | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.05 | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.46 | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.93 | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.36 | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.66 | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.70 | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.22 | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.00 | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.50 | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.50 | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.45 | – |
| Q3 FY2020 | Sep 30, 2020 | -$14.50 | – |
| Q2 FY2020 | Jun 30, 2020 | -$16.50 | – |
| Q1 FY2020 | Mar 31, 2020 | -$17.00 | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.46 | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.00 | – |
| Q2 FY2019 | Jun 30, 2019 | -$14.50 | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.50 | – |
| Q4 FY2018 | Dec 31, 2018 | -$12.98 | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.50 | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.50 | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.00 | – |
| Q4 FY2017 | Dec 31, 2017 | -$12.33 | – |
| Q3 FY2017 | Sep 30, 2017 | -$25.50 | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.50 | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.00 | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.61 | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.50 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?